The importance and effectiveness of cardiac screening in early diagnosis of critical congenital heart diseases

Aim: Cardiac screening test for early diagnosis of critical congenital heart disease (CCHD) is recommended by our ministry of health in newborns. We wanted to investigate the effectiveness of the pulse-oximetry screening test recommended by the ministry of health in our neonatal intensive care unit. Our study is planned to find an answer to this question regarding the subject matter. Materials and Methods: Our study was planned retrospectively in cases followed up in our neonatal intensive care unit and obstetrics and gynecology clinic. Our study cases were accepted to the neonatal service of our hospital starting from 01/10/2015 in the 30-month period. Patients admitted from the neonatal and obstetrics / gynecology services were included in the study. Saturation measurements of these cases were made at the earliest 6th hour after birth. The test was considered positive, if saturation was

PDF

___

1. Griebsch I, Knowles RL, Brown J, et al. Comparing the clinical and economic effects of clinical examination, pulse oximetry, and echocardiography in newborn screening for congenital heart defects: A probabilistic cost-effectiveness model and value of information analysis. Int J Technol Assess Health Care 2007;23:192-204.
2. Wren C, Richmond S, Donaldson L. Presentation of congenital heart disease in infancy: implications for routine examination. Arch Dis Child Fetal Neonatal Ed 1999;80:49-53.
3. Hoffman JIE. It is time for routine neonatal screening by pulse oximetry. Neonatology. 2011; 99:1-9. Wren C, Reinhardt Z, Khawaja K. Twenty tear trends in diagnosis of life threatening neonatal cardiovascular malformations. Arch Dis Child Fetal Neonatal Ed 2008; 93: 33-5.
4. Thangaratinam S, Brown K, Zamora J, et al. Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis. Lancet 2012:30;2459-64.
5. Kemper RA, Mahle WT, Martin GR, Cooley C, Kumar P, Morrow WR et al. Strategies for implementing screening for critical congenital heart disease. Pediatrics 2011;128:1259-67.
6. Martin GR, Beekman RH, Mikula EB, Fasules J, Garg LF, et. al. Pulse-oximetry screening AR, Implementing recommended screening for critical congenital heart disease. Pediatrics 2013;132:185-92.
7. Kemper AR, Hudak ML. Revisiting the Approach to Newborn Screening for Critical Congenital Heart Disease. Pediatrics. 2018:5;141-5.
8. Kochilas LK, Lohr JL, Bruhn E, et al. Implementation of critical congenital heart disease screening in Minnesota. Pediatrics 2013;132:587-94.
9. Roberts TE, Barton PM, Auguste PE, et al. Pulse oximetry as a screening test for congenital heart defects in newborn infants: a cost-effectiveness analysis. Arch Dis Child 2012;97:221-6.
10. Peterson C, Grosse SD, Glidewell J, et al. A public health economic assessment of hospitals' cost to screen newborns for critical congenital heart disease. Public Health Rep. 2014;129:86-93.